Skip to content

Various method of Ayurvedic management of URETHRAL STRICTURE.

A CLINICAL COMPERATIVE STUDY OF URETHRAL DILATATION WITH UTTARBASTI AND WITHOUT UTTARBASTI IN THE PREVENTION OF RECCURENCE OF URETHRAL STRICTURE.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019011
Enrollment
30
Registered
2019-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N359- Urethral stricture, unspecified

Interventions

Intervention1: 15 patients will be selected for Urethral dilatation with uttarbasti with the help of urethral dilator and Gokshur tail: under Suitable anaesthesia 4,cycle uttarbasti-in each cycle 20ml

Sponsors

GovtAkhandanand Ayurved College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 70 year Patient with history of stricture of urethra of mild to moderate symptoms will be selected for the study Controlled case of diabetes mellitus and hypertension Patients are selected irrespective of caste and religion

Exclusion criteria

Exclusion criteria: Patients with malignancy & infectious disease like HIV Age below 18 & above 70 Patients is impacted calculus in the urethra and bladder neck benign prostatic hyperplasia nephrotic syndrome and neoplasm of lower urinary tract Patients with systemic disease like HIV HBsAg uncontrolled DM and HTN Patients with coagulopathy like haemophilia

Design outcomes

Primary

MeasureTime frame
effect of uttarbasti ayurvedic management in urethral strictureTimepoint: assessment will be done after 7 days follow up will be done up to 2 month

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Rajesh kumar sharma

Govt.Akhandanand Ayurved College

dr.rajeshsharma38@gmail.com9408205584

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026